© Copyright 2001-2023 Erowid Center. DrugsData is a project of
Erowid Center. All rights reserved.
By using this site you agree not to publish its images, data, results, or analysis of its results without written permission from Erowid Center.
Permission is required before using data from DrugsData in any of these ways, including importing it into public or shared databases, software, or systems.
This policy has been in place since 2001 in order to require cooperation and credit by researchers and app authors.
Your javascript is turned off.
To remove this message, turn on javascript and accept the Terms of Use.
not DipyanoneSep 10 2021: We now believe this sample, originally considered unidentified by our lab, is Dipyanone. The reference standard for Dipyanone that was sent to our lab (pictured below, left) from Cayman in August was not correct. This is a very rare event.
This sample will be re-analyzed when the corrected standard for Dipyanone reaches the lab, expected by mid-October 2021.
Aug 4 2021: A Dipyanone standard was sourced and purchased, and this sample was re-analyzed.
Sample is not Dipyanone. It remains unidentified for now.Jun 8 2021: The mass spectrum for Dipipanone and the spectrum for the drug in this sample (pictured, left) are very similar, but not identical. (The Dipipanone one is also shown for comparison, bottom left.) Very little information and no certified standard available for Dipyanone, as of June 7, 2021.
The submitter says the sample was sold as 'Dipyanone', which we believe is the pyrrolidine analog of Dipipanone. Our analysis shows that this sample is not Dipipanone, but it could possibly be Dipyanone.